These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27294523)

  • 21. TGFβ signaling limits lineage plasticity in prostate cancer.
    Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
    PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
    Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
    Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
    Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
    Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
    Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
    Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.
    Nakazawa M; Kyprianou N
    J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
    Stoyanova T; Riedinger M; Lin S; Faltermeier CM; Smith BA; Zhang KX; Going CC; Goldstein AS; Lee JK; Drake JM; Rice MA; Hsu EC; Nowroozizadeh B; Castor B; Orellana SY; Blum SM; Cheng D; Pienta KJ; Reiter RE; Pitteri SJ; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6457-E6466. PubMed ID: 27694579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
    Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
    Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
    Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
    Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
    Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
    Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.
    Hill R; Song Y; Cardiff RD; Van Dyke T
    Cancer Res; 2005 Nov; 65(22):10243-54. PubMed ID: 16288012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch signaling in prostate cancer: refining a therapeutic opportunity.
    Su Q; Xin L
    Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
    Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
    Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pten dose dictates cancer progression in the prostate.
    Trotman LC; Niki M; Dotan ZA; Koutcher JA; Di Cristofano A; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Van Dyke T; Cordon-Cardo C; Pandolfi PP
    PLoS Biol; 2003 Dec; 1(3):E59. PubMed ID: 14691534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.
    Abou-Kheir WG; Hynes PG; Martin PL; Pierce R; Kelly K
    Stem Cells; 2010 Dec; 28(12):2129-40. PubMed ID: 20936707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch activation stimulates migration of breast cancer cells and promotes tumor growth.
    Bolós V; Mira E; Martínez-Poveda B; Luxán G; Cañamero M; Martínez-A C; Mañes S; de la Pompa JL
    Breast Cancer Res; 2013; 15(4):R54. PubMed ID: 23826634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss.
    O'Bryant D; Wang Z
    Oncogene; 2018 Jul; 37(30):4151-4163. PubMed ID: 29706654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.